Search

for
Search:

Research

5 / 1000+ results

research Who do we invent for? Patents by women focus more on women’s health, but few women get to invent

57 citations , June 2021 in “Science”

This study found that women's biomedical patents more often focus on women's health needs, highlighting how inventor representation can influence the diversity of inventions.

Female Patients Complaining About Hair Loss: Documentation of Defective Scalp Hair Dynamics with Contrast-Enhanced Phototrichogram

research Female patients complaining about hair loss: documentation of defective scalp hair dynamics with contrast-enhanced phototrichogram

23 citations , April 2006 in “Skin Research and Technology”

This study observed that hair density and growth rates vary by location and age, and the presence of thin hairs predominates in younger women with mild patterned hair loss.

research Female patients with androgenetic alopecia: immunohistochemical picture of scalp biopsies

September 2021 in “Eureka: Health Sciences”

This study found that female androgenetic alopecia is linked to oxidative stress, microinflammation, and fibrosis, suggesting these could be key targets for treatment improvements.

research Treating patients with female alopecia

1 citations , January 1996 in “Hair transplant forum international”

This article argues that the current model of female androgenic alopecia, based largely on traditional descriptive observations, has limitations and does not accurately represent the condition for most individuals.

research LB920 Patient-reported side effects of oral minoxidil in treating female pattern hair-loss

July 2024 in “Journal of Investigative Dermatology”

Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.

View more "female patients" in research →

Community Join

5 / 1000+ results

community Study: Dutasteride Mesotherapy Accelerates Hair Loss in Female Patients with Metabolic Syndrome

in Finasteride/Dutasteride 15 upvotes 2 years ago

Dutasteride mesotherapy in women with metabolic syndrome accelerated hair loss after initial regrowth, while women without metabolic syndrome saw continuous regrowth. The user with mild insulin resistance is hesitant to try topical dutasteride and seeks experiences from others with insulin resistance.

community Women complaining of bad effects from Winlevi (Clascoterone 1%)

11 upvotes 9 months ago

Women experienced severe reactions, including Topical Steroid Withdrawal (TSW), from using Winlevi (Clascoterone 1%) on their faces. Concerns were raised about the potential risks of higher concentrations, especially for hair loss treatment.

community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

55 upvotes 2 years ago

A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

community Positive Hair Result in Patient using Tirzepatide

4 upvotes 1 year ago

A 57-year-old man with male pattern hair loss and insulin resistance experienced hair regrowth and weight loss after using tirzepatide, without other hair treatments. Dysregulated glucose metabolism is linked to hair loss, with tirzepatide potentially improving hair density by normalizing insulin resistance.

community Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

90 upvotes 3 years ago

Kintor Pharma completed patient enrollment for a Phase II trial in China for GT20029, a potential new treatment for hair loss. Some believe GT20029 could replace finasteride if effective, while others discuss finasteride's limited efficacy and potential underreported side effects.

View more "female patients" in community →

Learn

7 / 801 results

learn Hair Transplant

When can I return to work after a hair transplant? Most patients can return to work within 2 to 7 days after a hair transplant.
Who is suitable for DHI hair transplant? Clinics say DHI suits men and women with several types of hair loss, but they also say suitability depends on donor supply, scalp condition and general health, and only a personal medical assessment can decide it.
What is the success rate of hair transplants? Hair transplants generally have a high success rate, but results can vary.
All 4 questions on Hair Transplant →

learn Scalp Micropigmentation

Is scalp micropigmentation safe? Providers describe scalp micropigmentation as low-risk when a trained practitioner uses sterile single-use equipment, but that is a provider claim rather than a regulatory finding: pigment allergy, infection and colour change are documented risks of cosmetic tattooing.

learn Overview

learn Minoxidil

An essential vasodilator with some anti-androgenic effects

learn Hair Multiplication

extract, clone, and reinsert your own hair cells

learn Dexpanthenol

precursor of vitamin B5 with hair stimulating effects

learn Neem Oil

natural substance from Neem tree with medicinal and pesticidal properties

View more "female patients" in learn →

Clinics

3 / 13 results

Experts

— no results

Try a deeper search in experts →